<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04168047</url>
  </required_header>
  <id_info>
    <org_study_id>2016/381/HP</org_study_id>
    <nct_id>NCT04168047</nct_id>
  </id_info>
  <brief_title>Are Sleeping Disorders Associated With Visceral Hypersensitivity in Irritable Bowel Syndrome Patients ?</brief_title>
  <acronym>S3i</acronym>
  <official_title>Are Sleeping Disorders Associated With Visceral Hypersensitivity in Irritable Bowel Syndrome Patients ?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Rouen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Rouen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Visceral hypersensitivity is frequent in IBS population up to 60% and is correlated with&#xD;
      severity and altered quality of life. Sleeping troubles are most frequent in IBS population.&#xD;
      Insomnia is a frequent disorder with an important cost for healthcare. Insomnia could&#xD;
      decrease pain threshold.&#xD;
&#xD;
      Visceral hypersensitivity was never measure in patients with insomnia. The hypothesis is IBS&#xD;
      patients with insomnia probably have lower visceral pain threshold.&#xD;
&#xD;
      The objective is to assess pain threshold during a barostat procedure in in IBS patients with&#xD;
      or without insomnia in comparison with healthy volunteers or patients with insomnia.&#xD;
&#xD;
      If the hypothesis are confirmed, insomnia should be look at in IBS patients and its&#xD;
      treatments could improve visceral hypersensitivity and IBS symptoms.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2020</start_date>
  <completion_date type="Anticipated">August 2023</completion_date>
  <primary_completion_date type="Anticipated">August 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pressure threshold measured during the barostat procedure</measure>
    <time_frame>Day 35</time_frame>
    <description>Pressure threshold measured during the barostat procedure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Score at HAD anxiety and depression scale</measure>
    <time_frame>Day 35</time_frame>
    <description>Score at HAD anxiety and depression scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Score at Pittsburg sleep quality index</measure>
    <time_frame>Day 35</time_frame>
    <description>Score at Pittsburg sleep quality index</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">77</enrollment>
  <condition>Irritable Bowel Syndrome</condition>
  <arm_group>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with insomnia</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with irritable bowel syndrome</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with irritable bowel syndrome and insomnia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Barostat procedure</intervention_name>
    <description>Pressure threshold will be measured during the barostat procedure</description>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_label>Patients with insomnia</arm_group_label>
    <arm_group_label>Patients with irritable bowel syndrome</arm_group_label>
    <arm_group_label>Patients with irritable bowel syndrome and insomnia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Anxiety and Depression Evaluation</intervention_name>
    <description>Anxiety and Depression will be measured using HAD anxiety and depression scale</description>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_label>Patients with insomnia</arm_group_label>
    <arm_group_label>Patients with irritable bowel syndrome</arm_group_label>
    <arm_group_label>Patients with irritable bowel syndrome and insomnia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Assessment of sleep quality</intervention_name>
    <description>Sleep quality will be measured using Pittsburg sleep quality index</description>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_label>Patients with insomnia</arm_group_label>
    <arm_group_label>Patients with irritable bowel syndrome</arm_group_label>
    <arm_group_label>Patients with irritable bowel syndrome and insomnia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Healthy volunteers&#xD;
&#xD;
             - Person aged over 18 years with no IBS and no Insomnia&#xD;
&#xD;
          2. Patients with insomnia&#xD;
&#xD;
             - Patient aged over 18 years with no IBS and no Insomnia&#xD;
&#xD;
          3. Patients with IBS&#xD;
&#xD;
             - Patient aged over 18 years with IBS&#xD;
&#xD;
          4. patients with insomnia and IBS - Patient aged over 18 years with IBS&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Active chronic organic disease&#xD;
&#xD;
          -  Endometriosis&#xD;
&#xD;
          -  Opioids consumption&#xD;
&#xD;
          -  Change in chronic treatment in the last 30 days&#xD;
&#xD;
          -  Hypersensitivity to Normacol&#xD;
&#xD;
          -  Patient with blood dyscrasia disorder known or identified, anticoagulant or&#xD;
             antiplatelet treatments&#xD;
&#xD;
          -  Rectal pathology&#xD;
&#xD;
          -  Intestinal occlusion&#xD;
&#xD;
          -  Severe renal failure&#xD;
&#xD;
          -  Sodium retention&#xD;
&#xD;
          -  Anal pathology (anal fissure, hemorrhoidal thrombosis)&#xD;
&#xD;
          -  Person with administrative or judicial decision or under legal protection measure&#xD;
&#xD;
          -  Patient participating in another trial in the last 30 days&#xD;
&#xD;
          -  Pregnant or breastfeeding women&#xD;
&#xD;
          -  Impossibility to keep fasting for 12 hours&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chloé MECHIOR, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rouen University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chloé MECHIOR, MD</last_name>
    <phone>+3323288</phone>
    <phone_ext>8990</phone_ext>
    <email>chloe.melchior@chu-rouen.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julien BLOT</last_name>
    <phone>+3323288</phone>
    <phone_ext>8265</phone_ext>
    <email>julien.blot@chu-rouen.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Rouen University Hospital</name>
      <address>
        <city>Rouen</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Chloé MELCHIOR, MD</last_name>
    </contact>
    <investigator>
      <last_name>Marie NETCHITAILO, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>November 15, 2019</study_first_submitted>
  <study_first_submitted_qc>November 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 19, 2019</study_first_posted>
  <last_update_submitted>June 26, 2020</last_update_submitted>
  <last_update_submitted_qc>June 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>visceral hypersensitivity</keyword>
  <keyword>Insomnia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Irritable Bowel Syndrome</mesh_term>
    <mesh_term>Parasomnias</mesh_term>
    <mesh_term>Hypersensitivity</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

